TrialCPT: pharmacometrics & systems pharmacology2025
Population Pharmacokinetic and Exposure-Response Analyses of Ibrutinib Combined With Bendamustine and Rituximab in Patients With Mantle Cell Lymphoma.
Per Olsson Gisleskog et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.